Oncology is a therapeutic area going through fundamental changes. These changes – driven by macroeconomic, competitive and scientific factors – are taking us many steps closer to making cancer a chronic condition, while keeping the overall cost of care within manageable boundaries.
The impact of these changes is being felt across the industry and by every player involved. The overall care ecosystem is feeling the need to evolve, innovate and grow.
The paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma. It also identifies the high-impact technologies that will affect the entire value-chain of cancer research and care delivery.